Sign in
4

Changes in Ownership

Evofem Biosciences, Inc. Filed Acc 0001209191-18-004299

Options or other derivatives

  • Chief Financial Officer acquired 23,099 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
File Justin J. Chief Financial Officer 2018-01-17 Grant or award · Stock Option (right to buy) +12,833 12,833 D
File Justin J. Chief Financial Officer 2018-01-17 Grant or award · Stock Option (right to buy) +10,266 10,266 D
Loading xslF345X03/doc4.xml…